Kymera Therapeutics, Inc. (KYMR)

121.05 +1.25 (+1.04%) USD  |  NASDAQ  |  Aug 24, 16:00
121.50 +0.45 (+0.37%) After-Hours: 07:00
More

Kymera Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. Upgrade